753 An open-label, phase 1a/b study of AB248, a CD8+ selective IL-2 mutein fusion protein, alone or in combination with pembrolizumab in patients with advanced solid tumors by Costantine Albany, Andrea Pirzkall, Michael Chisamore, Jennifer Visich, Elizabeth I Buchbinder, Xiaohan Liu, David R Spigel, Kelly D Moynihan, Christopher DelNagro, Matt Axt, Mark Sayles

1006 High doses of MHC-II neoantigens in peptide cancer vaccines induce tumor-specific inhibitory cytolytic CD4+ T cells by Naveen Sharma, James Allison, Andres Salazar, Hussein Sultan, Ton Schumacher, Ivana Djuretic, Yik Andy Yeung, Jeffrey Ward, Marco Colonna, Yuang Song, Samuel Ameh, Robert Schreiber, Kenneth Murphy, Yoshiko Takeuchi, Corazon Arthur, Kathleen Sheehan, Kelly D Moynihan, Vladimir Sukhov, Maria Firulyova, Tian-Tian Liu, Maxim Artyomov